STEPHANIE BREAULT: Open Payments
NPI 1699133751 · FREMONT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 25 payments from 17 companies in 2025. Trend: 2023 $254 · 2024 $664 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $95 |
| Alkermes, Inc. | 4 | $90 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Dexcom, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: CAPLYTA, VIVITROL, AUSTEDO XR, ARISTADA, Dexcom G6 Transmitter, Kerendia, Wegovy, XIFAXAN.
Industry payments across OH — which companies pay providers there.
